#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17850	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2206	804.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	979	C,T	928,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32636	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3609	901.0	0	.	n	.	0	T695C	SNP	695	695	T	990	990	C	1000	C	940	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32636	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3609	901.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1632	1632	A	1109	A,G	1019,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32636	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3609	901.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2266	2266	C	1079	C,T	1013,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32636	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3609	901.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2340	2340	A	1032	A	972	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32636	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3609	901.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2892	2892	C	1025	C,A	975,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2344	folP	852	852	100.0	folP.l15.c4.ctg.1	1534	151.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1054	1056	AGC	240;238;240	A;G;C	225;220;221	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5646	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3404	165.4	1	SNP	p	S91F	0	.	.	271	273	TCC	544	546	TCC	170;171;171	T;C;C	159;160;159	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5646	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3404	165.4	1	SNP	p	D95G	0	.	.	283	285	GAC	556	558	GAC	168;169;173	G;A;C	155;153;159	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5646	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3404	165.4	1	SNP	p	D95N	0	.	.	283	285	GAC	556	558	GAC	168;169;173	G;A;C	155;153;159	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1390	mtrR	633	633	97.47	mtrR.l6.c30.ctg.1	1517	91.4	0	.	p	.	0	D79N	NONSYN	235	237	GAT	597	599	AAT	181;182;180	A;A;T	173;175;174	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1390	mtrR	633	633	97.47	mtrR.l6.c30.ctg.1	1517	91.4	0	.	p	.	0	A86T	NONSYN	256	258	GCG	618	620	ACG	204;203;201	A;C;G	189;190;188	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1390	mtrR	633	633	97.47	mtrR.l6.c30.ctg.1	1517	91.4	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	675	677	CAC	234;234;231	C;A;C	225;219;219	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1390	mtrR	633	633	97.47	mtrR.l6.c30.ctg.1	1517	91.4	0	.	p	.	0	S183N	NONSYN	547	549	AGT	909	911	AAT	89;89;88	A;A;T	88;88;86	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1390	mtrR	633	633	97.47	mtrR.l6.c30.ctg.1	1517	91.4	0	.	p	.	0	M197I	NONSYN	589	591	ATG	951	953	ATA	72;76;76	A;T,C;A	68;71,1;72	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1390	mtrR	633	633	97.47	mtrR.l6.c30.ctg.1	1517	91.4	1	SNP	p	G45D	0	.	.	133	135	GGC	495	497	GGC	214;213;213	G;G;C	200;200;200	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5840	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3004	193.8	1	SNP	p	D86N	0	.	.	256	258	GAC	586	588	GAC	239;242;244	G;A;C	222;225;230	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5840	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3004	193.8	1	SNP	p	S87R	0	.	.	259	261	AGT	589	591	AGT	245;248;251	A;G;T	232;235;232	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5840	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3004	193.8	1	SNP	p	S87I	0	.	.	259	261	AGT	589	591	AGT	245;248;251	A;G;T	232;235;232	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5840	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3004	193.8	1	SNP	p	S87W	0	.	.	259	261	AGT	589	591	AGT	245;248;251	A;G;T	232;235;232	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5840	parC	2304	2304	100.0	parC.l6.c30.ctg.1	3004	193.8	1	SNP	p	S88P	0	.	.	262	264	TCC	592	594	TCC	254;256;257	T;C;C	238;241;244	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4854	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2579	187.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	248;245;242	G;G;C	223;221;216	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1254	1256	GCA	256;255;252	G;C;A	235;230;234	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1257	1259	ATC	254;252;256	A;T;C	235;235;239	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1269	1271	GTG	261;260;259	G;T;G	243;239;244	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1269	1271	GTG	261;260;259	G;T;G	243;239;244	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1773	1775	ACC	232;237;237	A;C;C	207;219;215	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1827	1829	GCG	243;237;235	G;C;G	217;184;195	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1827	1829	GCG	243;237;235	G;C;G	217;184;195	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1950	1952	GGC	201;199;192	G;G;C,T	187;182;177,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1959	1961	GGC	183;183;183	G,A;G;C	168,1;166;168	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4616	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2446	188.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1977	1979	CCG	157;163;163	C,G;C;G	125,2;133;135	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6602	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2999	218.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1598	1600	CTG	217;221;222	C;T;G	201;207;209	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2588	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1798	143.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	524	524	C	184	C	166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	0	.	p	.	0	I45V	NONSYN	133	135	ATT	514	516	GTT	277;277;274	G;T;T	263;257;260	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	0	.	p	.	0	I75V	NONSYN	223	225	ATT	604	606	GTT	290;289;290	G;T;T	269;255;270	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	0	.	p	.	0	S89T	NONSYN	265	267	AGC	646	648	ACC	294;299;303	A;C;C	249;269;275	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	0	.	p	.	0	I98V	NONSYN	292	294	ATC	673	675	GTC	287;287;288	G;T;C	262;259;264	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	0	.	p	.	0	Y213_N214insRYAY	INS	637	637	T	1018	1018	T	296	T	269	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	1	SNP	p	G120K	1	.	.	358	360	AAG	739	741	AAG	303;305;307	A;A;G	287;289;289	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	1	SNP	p	N121D	0	.	.	361	363	AAC	742	744	AAC	305;307;303	A;A,T;C	286;284,1;285	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3714	porB1b	1038	1038	98.38	porB1b.l15.c4.ctg.1	1642	225.1	1	SNP	p	A121N	1	.	.	361	363	AAC	742	744	AAC	305;307;303	A;A,T;C	286;284,1;285	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12664	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4887	258.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1971	1973	AAT	260;259;259	A;A;T	249;249;248	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1304	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1143	114.0	1	SNP	p	V57M	1	.	.	169	171	ATG	559	561	ATG	274;276;276	A;T;G	263;266;263	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
